Altered composition of triglyceride-rich lipoproteins and coronary artery disease in a large case-control study

被引:25
作者
Hopkins, Paul N. [1 ]
Nanjee, M. Nazeem [1 ]
Wu, Lily L. [1 ,2 ]
McGinty, Michael G. [1 ]
Brinton, Eliot A. [1 ]
Hunt, Steven C. [1 ]
Anderson, Jeffrey L. [3 ]
机构
[1] Univ Utah, Dept Internal Med, Div Cardiol, Sch Med, Salt Lake City, UT 84108 USA
[2] Univ Utah, Dept Pathol, Sch Med, Salt Lake City, UT 84108 USA
[3] Intermt Healthcare, Salt Lake City, UT USA
关键词
Plasma triglycerides; VLDL; Lipids; Ultracentrifugation; Type III hyperlipidemia; Dysbetalipoproteinemia; Coronary artery disease; HDL cholesterol; CHOLESTERYL ESTER TRANSFER; LOW-DENSITY-LIPOPROTEIN; TRANSFER PROTEIN GENE; APOLIPOPROTEIN-C-III; CLINICS PROGRAM PREVALENCE; HEART-DISEASE; HUMAN-SERUM; HDL CHOLESTEROL; RISK-FACTORS; FAMILIAL HYPERCHOLESTEROLEMIA;
D O I
10.1016/j.atherosclerosis.2009.05.016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Traditional beta-quantification of plasma lipoproteins by ultracentrifugation separates triglyceride-rich lipoproteins (TGRL) from higher density lipoproteins. The cholesterol in the TGRL fraction is referred to as measured very low-density lipoprotein cholesterol (VLDL-C) recognizing that other TGRL may be present. The measured VLDL-C to total plasma triglyceride (VLDL-C/TG) has long been considered an index of average TGRL composition with abnormally high VLDL-C/TG ratios (>= 0.30 with TG>150 mg/dL) indicative of atherogenic remnant accumulation (type III hyperlipidemia). However, virtually no reports are available which examine potential associations between CAD and VLDL-C/TG at the lower end of the spectrum. Methods and results: We performed ultracentrifugation in 1170 cases with premature-onset, familial CAD and 1759 population-based controls and examined the VLDL-C/TG ratio as an index of TGRL composition. As expected, we found very high CAD risk associated with severe type III hyperlipidemia (OR 10.5, p = 0.02). Unexpectedly, however, we found a robust, graded, and independent association between CAD risk and lower than average VLDL-C/TG ratios (p < 0.0001 as ordered categories or as a continuous variable). Among those in the lowest VLDL-C/TG category (a ratio < 0.12), CAD risk was clearly increased (OR 4.5, 95% CI 2.9-6.9) and remained significantly elevated in various subgroups including those with triglycerides below 200 mg/dl, in males and females separately, as well as among those with no traditional CAD risk factors (OR 5.8, 95% CI 1.5-22). Significant compositional differences by case status were confirmed in a subset whose samples were re-spun with measurement of lipids and apolipoprotein B (apo B) in each subfraction. Conclusions: We found a strong, graded, independent, and robust association between CAD and lower VLDL-C/TG ratios. We consider this a novel, hypothesis-generating observation which will hopefully generate additional future studies to provide confirmation and further insight into potential mechanisms. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:559 / 566
页数:8
相关论文
共 95 条
  • [1] Agerholm-Larsen B, 2000, CIRCULATION, V102, P2197
  • [2] TYPE-3 HYPERLIPOPROTEINEMIA - COMPARATIVE-STUDY OF CURRENT DIAGNOSTIC TECHNIQUES
    ALBERS, JJ
    WARNICK, GR
    HAZZARD, WR
    [J]. CLINICA CHIMICA ACTA, 1977, 75 (02) : 193 - 204
  • [3] Genetic polymorphisms of hepatic lipase and cholesteryl ester transfer protein, intermediate phenotypes, and coronary risk - Do they add up yet?
    Anderson, JL
    Carlquist, JF
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (11) : 1990 - 1993
  • [4] Lipoprotein genotype and conserved pathway for exceptional longevity in humans
    Atzmon, G
    Rincon, M
    Schechter, CB
    Shuldiner, AR
    Lipton, RB
    Bergman, A
    Barzilai, N
    [J]. PLOS BIOLOGY, 2006, 4 (04) : 562 - 569
  • [5] Avramoglu RK, 1995, J LIPID RES, V36, P2513
  • [6] Effects of torcetrapib in patients at high risk for coronary events
    Barter, Philip J.
    Caulfield, Mark
    Eriksson, Mats
    Grundy, Scott M.
    Kastelein, John J. P.
    Komajda, Michel
    Lopez-Sendon, Jose
    Mosca, Lori
    Tardif, Jean-Claude
    Waters, David D.
    Shear, Charles L.
    Revkin, James H.
    Buhr, Kevin A.
    Fisher, Marian R.
    Tall, Alan R.
    Brewer, Bryan
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (21) : 2109 - 2122
  • [7] Unique lipoprotein phenotype and genotype associated with exceptional longevity
    Barzilai, N
    Atzmon, G
    Schechter, C
    Schaefer, EJ
    Cupples, AL
    Lipton, R
    Cheng, S
    Shuldiner, AR
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (15): : 2030 - 2040
  • [8] Postprandial enrichment of remnant lipoproteins with ApoC-I in healthy normolipidemic men with early asymptomatic atherosclerosis
    Björkegren, J
    Silveira, A
    Boquist, S
    Tang, R
    Karpe, F
    Bond, MG
    de Faire, U
    Hamsten, A
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (09) : 1470 - 1474
  • [9] Common genetic variation of the cholesteryl ester transfer protein gene strongly predicts future cardiovascular death in patients with coronary artery disease
    Blankenberg, S
    Rupprecht, HJ
    Bickel, C
    Jiang, XC
    Poirier, O
    Lackner, KJ
    Meyer, J
    Cambien, F
    Tiret, L
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (11) : 1983 - 1989
  • [10] PREDICTION OF ANGIOGRAPHIC CHANGE IN NATIVE HUMAN CORONARY-ARTERIES AND AORTOCORONARY BYPASS GRAFTS - LIPID AND NONLIPID FACTORS
    BLANKENHORN, DH
    ALAUPOVIC, P
    WICKHAM, E
    CHIN, HP
    AZEN, SP
    [J]. CIRCULATION, 1990, 81 (02) : 470 - 476